Group 1 - Spring Medical announced a dividend of HKD 0.2304 per share, with an ex-dividend date of November 24, 2025, and a payment date of January 19, 2026. It is classified under the medical devices and supplies sector and is not part of the CSI Central Enterprises Dividend Index or the Hang Seng High Dividend Yield Index [1] - NetEase-S declared a dividend of USD 0.114 per share, with an ex-dividend date of December 4, 2025, and a payment date of December 16, 2025. It falls under the gaming software sector and is excluded from both the CSI Central Enterprises Dividend Index and the Hang Seng High Dividend Yield Index [1] - Kingsoft Technology Industrial announced a dividend of HKD 0.018 per share, with an ex-dividend date of December 24, 2025, and a payment date of January 8, 2026. It is categorized under consumer electronics and is not included in the CSI Central Enterprises Dividend Index or the Hang Seng High Dividend Yield Index [1] - Sa Sa International declared a dividend of HKD 0.0115 per share, with an ex-dividend date of December 3, 2025, and a payment date of December 19, 2025. It is classified in the skincare and cosmetics sector and is not part of the CSI Central Enterprises Dividend Index or the Hang Seng High Dividend Yield Index [1] Group 2 - The CSI Central Enterprises Dividend Index (931233.CSI) selects 50 listed companies with stable dividend levels and high dividend yields from the Hong Kong Stock Connect. As of November 20, the index has a one-year dividend yield of 5.63%, surpassing the 10-year government bond yield of 3.81%. The largest investment vehicle tracking this index is the Hong Kong Central Enterprises Dividend ETF (513910) [3] - The Hang Seng Mainland Enterprises High Dividend Yield Index (HSMCHYI.HI) includes high dividend stocks listed in Hong Kong from mainland companies. As of November 20, this index has a one-year dividend yield of 5.30%, which is higher than the 10-year government bond yield of 3.48%. The only ETF tracking this index is the Hang Seng Dividend ETF (159726) [3]

Group 1 - Spring Medical announced a dividend of HKD 0.2304 per share, with an ex-dividend date of November 24, 2025, and a payment date of January 19, 2026. It is classified under the medical devices and supplies sector and is not part of the Central Enterprises Dividend Index or the High Dividend Yield Index for Mainland Chinese Enterprises [1] - NetEase-S declared a dividend of USD 0.114 per share, with an ex-dividend date of December 4, 2025, and a payment date of December 16, 2025. It falls under the gaming software sector and is also excluded from the aforementioned indices [1] - Kingsoft Technology Industrial announced a dividend of HKD 0.018 per share, with an ex-dividend date of December 24, 2025, and a payment date of January 8, 2026. It is categorized under consumer electronics and is not included in the Central Enterprises Dividend Index or the High Dividend Yield Index [1] - Sa Sa International declared a dividend of HKD 0.0115 per share, with an ex-dividend date of December 3, 2025, and a payment date of December 19, 2025. It is classified in the skincare and cosmetics sector and is excluded from both indices [1] Group 2 - The Central Enterprises Dividend Index (931233.CSI) selects 50 listed companies with stable dividend levels and high dividend yields from the Hong Kong Stock Connect. As of November 20, the index has a one-year dividend yield of 5.63%, surpassing the 10-year government bond yield of 3.81%. The largest investment vehicle tracking this index is the Hong Kong Central Enterprises Dividend ETF (513910) [3] - The Hang Seng Mainland Enterprises High Dividend Yield Index (HSMCHYI.HI) includes high dividend stocks listed in Hong Kong from Mainland companies. As of November 20, this index has a one-year dividend yield of 5.30%, which is higher than the 10-year government bond yield of 3.48%. The only ETF tracking this index is the Hang Seng Dividend ETF (159726) [3]

Core Viewpoint - The stock of Heartway Medical (02291.HK) has experienced significant volatility, with a peak increase of 100% before settling at a 76% rise, currently priced at 28.25 HKD [1] Group 1 - Heartway Medical's stock triggered the market adjustment mechanism three times, entering a cooling-off period [1] - The stock's price surged to a high of 28.25 HKD, reflecting strong investor interest and market activity [1]